Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy

I. Christiaans, E. Birnie, G.J. Bonsel, M.M.A.M. Mannens, M. Michels, D. Majoor-Krakauer, D. Dooijes, J.P. van Tintelen, M.P. van den Berg, P.G.A. Volders, Y.H. Arens, A. van den Wijngaard, D.E. Atsma, A.T.J.M. Helderman-van Enden, A.C. Houweling, K. de Boer, J.J. van der Smagt, R.N.W. Hauer, C.L.M. Marcelis, J. TimmermansI.M. van Langen, A.A.M. Wilde

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1161-1170
JournalEuropean Heart Journal
Volume32
Issue number9
DOIs
Publication statusPublished - 2011

Cite this